Bank Of Nova Scotia Edwards Lifesciences Corp Transaction History

Bank Of Nova Scotia

$52.2 Billion
Q4 2024

A detailed history of Bank Of Nova Scotia transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Bank Of Nova Scotia holds 216,604 shares of EW stock, worth $15.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

216,604

Previous 180,259 20.16%

Holding current value

$15.8 Million

Previous $11.9 Million 34.8%

% of portfolio

0.03%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$64.54 - $75.92 $2.35 Million - $2.76 Million	36,345 Added 20.16%	216,604 $16 Million
Q3 2024 Nov 13, 2024	BUY	$59.7 - $93.78 $203,636 - $319,883	3,411 Added 1.93%	180,259 $11.9 Million
Q2 2024 Aug 14, 2024	SELL	$84.3 - $94.31 $63.7 Million - $71.3 Million	-755,915 Reduced 81.04%	176,848 $16.3 Million
Q1 2024 May 14, 2024	BUY	$72.54 - $95.56 $41.3 Million - $54.4 Million	569,144 Added 156.52%	932,763 $89.1 Million
Q4 2023 Feb 12, 2024	SELL	$61.71 - $77.76 $21.5 Million - $27.1 Million	-348,691 Reduced 48.95%	363,619 $27.7 Million
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $25.3 Million - $34 Million	364,563 Added 104.84%	712,310 $49.3 Million
Q2 2023 Aug 03, 2023	SELL	$81.41 - $94.33 $4.72 Million - $5.47 Million	-58,003 Reduced 14.3%	347,747 $32.8 Million
Q1 2023 May 11, 2023	SELL	$74.26 - $84.51 $36.9 Million - $41.9 Million	-496,242 Reduced 55.02%	405,750 $33.6 Million
Q4 2022 Feb 09, 2023	BUY	$68.3 - $87.44 $33.6 Million - $43 Million	492,193 Added 120.11%	901,992 $67.3 Million
Q3 2022 Nov 10, 2022	BUY	$82.37 - $107.29 $419,922 - $546,964	5,098 Added 1.26%	409,799 $33.8 Million
Q2 2022 Aug 11, 2022	BUY	$86.5 - $128.27 $2.34 Million - $3.47 Million	27,090 Added 7.17%	404,701 $38.5 Million
Q2 2022 Aug 08, 2022	SELL	$86.5 - $128.27 $50.3 Billion - $74.6 Billion	-581,712,108 Reduced 99.94%	377,611 $36 Million
Q2 2022 Aug 05, 2022	BUY	$86.5 - $128.27 $50.3 Billion - $74.6 Billion	581,671,529 Added 139092.64%	582,089,719 $27.4 Billion
Q1 2022 May 09, 2022	SELL	$101.96 - $128.34 $64.4 Million - $81.1 Million	-631,991 Reduced 60.18%	418,190 $49.2 Million
Q4 2021 Feb 11, 2022	BUY	$106.37 - $130.68 $44.5 Million - $54.7 Million	418,306 Added 66.2%	1,050,181 $136 Million
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $5.96 Million - $7.11 Million	-57,892 Reduced 8.39%	631,875 $71.5 Million
Q2 2021 Aug 12, 2021	BUY	$83.84 - $104.76 $57.8 Million - $72.3 Million	689,767 New	689,767 $71.4 Million

Others Institutions Holding EW

# of Institutions

1,381

Shares Held

487M

Call Options Held

6.71M

Put Options Held

3.17M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Nova Scotia with notifications on news.

Account

Bank Of Nova Scotia Edwards Lifesciences Corp Transaction History